Can open-source R&D reinvigorate drug research?
作者信息
Munos Bernard
机构信息
Bernard Munos is at Eli Lilly & Co., Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA.
出版信息
Nat Rev Drug Discov. 2006 Sep;5(9):723-9. doi: 10.1038/nrd2131. Epub 2006 Aug 18.
DOI:10.1038/nrd2131
PMID:16915233
Abstract
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?
摘要
Zotero 插件